INTRODUCTION
Osteopontin (secreted phosphoprotein 1, 2 ar) is a secreted adhesive glycoprotein with a GRGDS cell-binding domain (Oldberg et al., 1986; Craig et al., 1989; Kiefer et al., 1989; Wrana et al., 1989) . This motif is present in fibronectin, vitronectin, and a variety of other extracellular proteins that bind members of the integrin family of cell surface receptors (Ruoslahti, 1991; Hynes, 1992) . Consistent with the presence of a GRGDS cellbinding sequence, substratum-bound osteopontin from bone promotes attachment and spreading of cells in vitro, and cell attachment is blocked by soluble GRGDS peptides (Oldberg et al., 1986; Somerman, et al., 1989) . Moreover, a monoclonal antibody to the integrin a^v3 has been reported to block osteopontin-stimulated changes in osteoclast cytosolic calcium, suggesting that osteopontin is a ligand for integrin aV03 (Miyauchi et al., 1991) .
The prominence of osteopontin in bone matrix and the regulation of its expression by osteotropic hormones have focused attention on the role of this protein in bone development and remodeling (Prince and Butler, 1987; Yoon et al., 1987; Kubota et al., 1989; Noda et al., 1990; Reinholt et al., 1990; Chen et al., 1991; Moore et al., 1991) . However, several laboratories have shown that osteopontin mRNA is expressed by a number of tissues, including kidney, ovary, uterus, and others (Yoon et al., 1987; Nomura et al., 1988; Denhardt et al., 1989; Young et al., 1990; Craig and Denhardt, 1991) . Thus, prior studies have suggested that osteopontin is expressed in tissues other than bone; however, the specific cellular sites of osteopontin synthesis and deposition in most of these tissues have not been investigated, and other tissues have never been examined for osteopontin expression. Therefore, to provide a more comprehensive picture of the normal tissue and cell distribution of osteopontin mRNA and protein, we prepared RNA and cDNA probes and affinity-purified antibodies and used these reagents to perform in situ hybridization, Northern analyses, and immunohistochemistry on a variety of normal adult human tissues. Our studies have revealed a previously unrecognized and unifying pattern of osteopontin expression and localization in normal adults, i.e., this adhesive protein is present on luminal surfaces of many epithelial cells communicating with the external environment.
MATERIALS AND METHODS
Osteopontin Purification and Affinity-Purified
Antibodies
Osteopontin was purified to homogeneity from human milk as described previously (Senger et al., 1989b) . As determined by sodium dodecyl sulfate (SDS) polyacrylamide gels, these osteopontin preparations contained a single protein, and N-terminal sequence analyses revealed a single sequence identical to that of osteopontin (Senger et al., 1989a,b) . For additional assurance of protein purity, osteopontin for immunization of rabbits was subjected to electrophoresis in SDS polyacrylamide gels, the gels were stained, and the osteopontin bands were excised. Rabbits were immunized with pulverized polyacrylamide slices containing 60 ,g osteopontin together with complete Freund's adjuvant and boosted twice with one-half the amount of the same antigen mixed with incomplete adjuvant at 3-w intervals. Antisera obtained stained osteopontin antigen on immunoblots. To eliminate other antibodies that might be present in whole rabbit serum, we affinity-purified osteopontin antibody. For affinity-purification of antibody, an osteopontin-Sepharose column was prepared by coupling 300 yg purified osteopontin to 3.5 ml cyanogen bromide-activated Sepharose (Pharmacia, Piscataway, NJ). Fifteen milliliters of antiserum was passed over the column, and after washing, bound antibody was eluted with 15 ml 0.1 M glycine, pH 2.5, and immediately neutralized with 2 ml of 1 M tris(hydroxymethyl)aminomethane, pH 8.0. Affinitypurified antibody preparations obtained were of concentrations typically 0.3-0.6 mg/ml. To assure for specific-staining, only affinitypurified antibody was used in immunohistochemistry (see below).
Tissue Selection
Immunohistochemical staining was performed on archival formalinfixed paraffin-embedded material. Blocks containing normal tissue without microscopic abnormalities were chosen for these studies. Fresh tissues for Northern blots and in situ hybridization were selected from grossly normal areas of resected surgical specimens.
Immunohistochemical Staining
All staining was performed on the Histomatic Slide Stainer, CodeOn Series (Fisher Scientific, Pittsburgh, PA). Staining was accomplished in a two-step procedure using affinity-purified osteopontin antibody typically at 1:50 dilution, followed by peroxidase-labeled anti-rabbit IgG antibodies. Final color development was achieved with 3-amino-9-ethyl carbazole. Slides were counterstained with hematoxalin. Negative controls were performed substituting rabbit IgG at a concentration equal to that of the affinity-purified osteopontin antibody.
cDNA Cloning and Probe Preparation
A human mammary gland cDNA library in Xgtll(HL1037b) was obtained from Clontech Laboratories (Palo Alto, CA). Plaques were obtained by plating the library on Escherichia coli strain Y1090 and screened with affinity-purified osteopontin antibody. A total of 1.8 X l05 phage plaques were screened, and one positive clone was obtained. The positive plaque was recovered from agar and replated for secondary screening. DNA was prepared from the positive clone by polyethylene glycol precipitation of phage lysate followed by phenol/ chloroform extraction and ethanol precipitation. The cloned insert was recovered by polymerase chain reaction (PCR) amplification with Xgtll-specific primers (New England Biolabs, Beverly, MA). The cloned insert (-1.5 kilobase [kb] in size) was then subjected to restriction mapping that confirmed that it represented osteopontin cDNA (Kiefer et al., 1989) . Further proof of the identity of the Xgtll clone was obtained by subcloning its 330-base pair (bp) portion located between EcoRI and HindIll restriction sites. This DNA fragment was inserted into an M13 vector and sequenced using the chain termination method (Sequenase kit, United States Biochemical, Cleveland, OH). The DNA sequence is identical to the previously reported osteopontin cDNA sequence (Kiefer et al., 1989) . The entire 1.5-kb PCR product was used as a probe in the Northern blotting experiments (see below).
Northern Analysis
RNA isolation and blotting were performed as described previously (Berse et al., 1992 (Sambrook et al., 1989) . DNA probes were labeled with [a-32P]dCTP (New England Nuclear, Boston, MA) to a specific activity of 1-2 X 109 cpm/;g DNA using the oligolabeling kit (Pharmacia). Final washes were in 2X SSC, 0.1% SDS at 65°C. The blots were exposed to Kodak (Rochester, NY) XAR-2 film with an intensifying screen at -70°C, typically for 1-4 d. To control for total mRNA content and lack of degradation, the blots were stripped and subsequently rehybridized with a human ,B-actin probe (Clontech Laboratories).
In Situ Hybridization
To construct a template for probe synthesis, the 330-bp EcoRI-HindIII fragment of the osteopontin cDNA (corresponding to the 3' end of the coding region and extending 200 bp into the 3' untranslated region) was inserted into plasmid pGEM-3Zf(+) (Promega, Madison, WI) . To obtain the antisense RNA probe, the pGEM construct with osteopontin insert was linearized with EcoRI and transcribed in vitro from the SP6 polymerase promoter; alternatively, the same construct was linearized with HindIII and transcribed from the T7 promoter to yield the sense (control) probe. Transcription reactions were carried out using a Riboprobe Gemini II kit (Promega) in the presence of [a-35S]UTP (Dupont New England Nuclear Products, Boston, MA). The probes were purified by gel electrophoresis, and in situ hybridization on tissues processed through paraffin was performed as described previously (Berse et al., 1992) . In addition, some in situ hybridization experiments were performed on frozen sections. Tissue was fixed for 4 h at 4°C in 4% paraformaldehyde (prepared in phosphate-buffered saline [PBS] ) and then transferred to 30% sucrose in PBS at 4°C overnight. Tissue was then embedded in O.C.T. compound (Miles Laboratories, Elkhardt, IN), and 5-aum frozen sections were cut on a cryostat. In situ hybridization on frozen sections was performed as on paraffin sections but deparafinization steps were omitted.
Immunoblotting of Bile Proteins
Barium citrate adsorption of osteopontin from bile was performed as descrbed previously for adsorption of osteopontin from blood plasma (Senger et al., 1988) and adsorption of osteopontin from breast milk (Senger et al., 1989b) . The barium-citrate adsorbed proteins from 40 ml of bile were eluted with 4 ml of 0.2 M of sodium citrate, pH 6.8, and 80-,il aliquots of eluate were subjected to SDS polyacrylamide gel electrophoresis (Laemmli, 1970) , followed by a transfer to nitrocellulose as described previously (Senger et al., 1988) . Samples were heated and reduced before electrophoresis. Blots were stained with osteopontin antiserum or control rabbit serum followed by ["25I] protein A (Dupont New England Nuclear Products) and visualized with autoradiography (see Northern blotting, above).
Cell Lines and Cell Attachment Assays
CCD-18Co human colon fibroblasts and HISM human intestinal smooth muscle cells were obtained from the American Type Culture Collection (Rockville, MD). The K-16 cell line was derived from normal adult rat liver epithelium (Weinstein et al., 1975) and obtained from Dr. R. 0. Hynes, Massachusetts Institute of Technology (Cambridge, MA). For cell attachment assays (Ruoslahti et al., 1982) , we used tissue culture plastic (Costar, Cambridge, MA) coated with 6 jig/ml purified human osteopontin (37°C, 1 h) followed by incubation with 20 mg/ ml bovine serum albumin (BSA, A7030; Sigma, St. Louis, MO) at 37°C, 1 h. Plastic coated with BSA alone did not promote any cell attachment or spreading. We found more efficient coating with osteopontin if performed in 0.1 M glycine, pH 3.0, rather than at neutral pH, probably because human milk osteopontin has a low isoelectric point (about pH 3.0-3.5; our unpublished results). Cells were plated in serum-free medium; attachment and spreading was monitored microscopically for up to 24 h. GRGDSP and glycine-arginine-glycineglutamate-serine-proline (GRGESP) peptides were purchased from Telios Pharmaceuticals (San Diego, CA).
RESULTS
Osteopontin protein and mRNA were found to be widely distributed in a variety of normal adult human tissues as determined by immunohistochemistry, in situ hybridization, and Northern blotting (Table 1, Gastrointestinal Tract, Gallbladder, Bile Ducts, Pancreas, and Salivary Glands Widespread intense immunohistochemical staining for osteopontin was observed in many glandular epithelial cells that lined levels of the gastrointestinal tract, including the stomach, small intestine ( Figure 1D ), appendix, and large bowel ( Figure 1F) ; staining was particularly pronounced at the epithelial cell-luminal interface ( Figure 1 , Table 1 ). The epithelium lining the gall bladder, the intrahepatic bile ducts, and both large and small pancreatic ducts stained in a similar fashion (Figure 1, C Figure 1E ).
These immunohistochemical findings were supported further by Northern blotting and in situ hybridization. A 1.5-kb osteopontin transcript was found by Northern analyses in gallbladder, small intestine, colonic mucosa, colonic wall, stomach, and liver ( Figure 2 , Table 1 ). Relative to other tissues, gallbladder contained particularly high levels of osteopontin mRNA. Northern analyses detected relatively low levels of osteopontin mRNA in scrapings of colonic mucosa, though higher levels were found in colonic wall. In situ hybridization demonstrated osteopontin mRNA in gallbladder epithelium (Figure 3, and in the epithelium of pancreatic ducts (Figure 4, c and d) . In the few cases examined, osteopontin transcript was not detected in intestinal epithelium with in situ hybridization; however, the intermuscular ganglion cells were strongly positive (Figure 3, g and h) . In view of these findings, it is likely that the osteopontin mRNA detected in colonic wall by Northern analysis represented osteopontin mRNA present in bowel wall ganglion cells rather than muscle cells, which contained no detectable osteopontin (by immunohistochemistry) or osteopontin mRNA (by in situ hybridization).
In accord with these immunohistochemical and mRNA analyses, immunoblotting revealed the presence of osteopontin in bile ( Figure 5 ). Whereas osteopontin isolated from human milk exhibited an electrophoretic mobility of approximately Mr 75 000 (Senger et al., 1989b) , bile proteins contained not only that species but also lower and higher molecular weight forms. The former may represent proteolytic breakdown products, whereas the latter may represent polymers formed through covalent cross-linking of osteopontin to itself or to other bile proteins (see DISCUSSION). Taken together, these data indicate that osteopontin mRNA is transcribed and that osteopontin protein is synthesized in the gallbladder epithelium and subsequently secreted into the bile. and SC2 superficial colon (mucosa) samples 1 and 2. Il, ileum; En, endometrial epithelium; Br, breast; DC1 and DC2, deep colon (wall with muscle layers) samples 1 and 2; GB, gallbladder; Ki, kidney. Exposure time: 66 h. (B) Same as A, but short exposure (2.5 h). Distortion due to sample composition appears to be responsible for the slight variations in mRNA mobility. Relative quantities of osteopontin transcript, similar to that detected in superficial colon mucosa (SC), were also found in stomach, liver, and lung (not shown).
Urinary Tract Antibody to osteopontin stained the cytoplasm of many epithelial cells lining the distal tubules and collecting ducts of the kidney (Figure 1, I and J), as well as the transitional epithelium of the renal pelvis. In accord with these findings, in situ hybridization localized osteopontin mRNA predominantly to epithelial cells of the distal tubules ( Figure 3 , e and f), and Northern analysis of normal adult kidney revealed relatively high levels of 1.5 kb osteopontin mRNA (Figure 2 ). Antibody also stained the transitional epithelium of the bladder focally, limited in some cases to the most superficial epithelial cells ( Figure 1K ).
Male and Female Genital Tracts
In the male genital tract, immunostaining for osteopontin was observed focally in epithelial cells of the prostate ( Figure 1T ) and in ductal epithelium of the mediastinum In the female genital tract, the mucinous epithelium of the endocervix stained strongly and diffusely with antibody to osteopontin, as did the hypersecretory endometrial gland epithelium associated with pregnancy ( Figure 1, 0 and P) . Secretory endometrium taken from nonpregnant subjects also stained focally and in situ hybridization demonstrated osteopontin transcript in the secretory gland epithelium (Figure 4, a and b) . Northern blotting identified osteopontin mRNA in extracts of superficial endometrial and endocervical tissue (Figure 2 ), whereas at comparable autoradiographic exposures none was detected in uterine muscle. The epithelium lining the fallopian tubes reacted focally with anti-osteopontin antibody ( Figure 1Q ), giving an accentuated band of staining at the luminal surface and in situ hybridization localized osteopontin mRNA to luminal epithelial cells (Figure 3, i-l Figure 1A ). In contrast, staining in sections of nonlactating breast was limited to occasional duct epithelial cells. Our antibody to milk osteopontin recognized osteopontin in bone, demonstrating prominent immunohistochemical staining of the cement lines and surfaces of mature bone trabeculae ( Figure 1B ). In the lung, antibody to osteopontin stained bronchial columnar epithelium focally, most prominently at the luminal surface ( Figure 1M ). Staining was also observed in epithelial cells of the bronchial mucous glands ( Figure 1N ). The presence of osteopontin mRNA in adult human lung was confirmed by Northern blotting. In the skin, strong immunostaining was found in sweat duct epithelium with an accentuated band of staining at the luminal surface; weaker staining was also observed in sweat gland epithelium ( Figure 1L ). Mesothelial cells lining the peritoneal surface stained focally with osteopontin antibody. Immunostaining in the placenta was found in isolated cells lining the amniotic cavity and in occasional cells within the stroma of placental villi (Figure 1, R and S).
Finally, a variety of tissues did not stain detectably with osteopontin antibody; these included lymph nodes, spleen, skeletal muscle, and connective tissue.
Cell Attachment and Spreading Directed by Epithelial Osteopontin Osteopontin isolated from bone has been shown previously to promote cell attachment and spreading (Oldberg et al., 1986; Somerman et al., 1989) . To determine if osteopontin secreted by epithelium is also capable of promoting cell attachment and spreading, we purified osteopontin to homogeneity from human milk and used it in cell attachment assays. For these experiments, plastic wells were initially coated with osteopontin (6 ,ug/ ml), and then, to eliminate nonspecific adherence of cells to plastic, wells were blocked with BSA (20 mg/ ml). Thus, any cell attachment and spreading observed were directed by osteopontin and not by the underlying plastic substratum. As shown in Figure 6 (a-c), osteopontin purified from milk promoted attachment and spreading of human colon fibroblasts, rat epithelial cells derived from normal rat liver, and human intestinal smooth muscle cells. Cell attachment appeared to be dependent on the arginine-glycine-aspartate (RGD) domain of osteopontin because soluble GRGDSP peptide (300 ,uM) blocked this process completely, whereas control peptide GRGESP was without effect. No cell attachment occurred in wells coated with BSA alone (Figure 6d ).
DISCUSSION
In this study, we have demonstrated for the first time widespread presence of osteopontin on specific populations of luminal epithelial cells in the human gastrointestinal tract, gallbladder, bile ducts, pancreatic ducts, urinary and reproductive tracts, bronchi, lactating breast, sweat ducts and glands, and salivary ducts and glands. Moreover, we have demonstrated widespread expression of osteopontin mRNA by luminal epithelia and have determined that the gallbladder is a major site of osteopontin expression, comparable in magnitude with that of kidney. Prior studies with animal models identified osteopontin mRNA in several tissues and organs; however, in most cases, the cellular localization of the protein and the identity of the cells responsible for its synthesis were not established. Our findings of widespread accumulation of osteopontin on the surfaces of many epithelia communicating with the external environment are particularly significant and suggest that this protein plays an important role at these surfaces.
The relatively high levels of osteopontin mRNA in gall bladder, relative to bowel mucosa, together with the presence of osteopontin in bile, raise the possibility that osteopontin secreted into bile may contribute much of the osteopontin detected on the mucosal surfaces of the small and large intestines. Moreover, our data suggest that osteopontin at these sites may exist in polymeric forms. Immunoblotting of bile proteins identified not only osteopontin and osteopontin fragments but also high molecular weight complexes. These high molecular weight complexes did not dissociate in the presence of SDS, reducing agent, and heat and thus may have resulted from covalent cross-linking of osteopontin either to itself or to other bile components. Osteopontin has been shown previously to be a substrate for hepatic transglutaminase that catalyzes cross-linking of glutamine and lysine residues (Beninati et al., 1991; Prince et al., 1991) .
In the adult human kidney, osteopontin transcripts were found predominantly in the epithelial cells of distal tubules. By immunohistochemistry, osteopontin was were the major site of synthesis in human kidney. Osteopontin recently has been found in human urine (Shiraga et al., 1992) , raising the possibility that some of the protein synthesized is released into the lumen. Thus, osteopontin is present in at least three bodily fluids, including urine, bile ( Figure 5 ), and milk (Senger et al., 1989b) . Our immunohistochemical findings also raise the possibility that osteopontin is secreted by epithelial cells into saliva and sweat.
Osteopontin mRNA expression has been found to be elevated in the skin and breast tissue of pregnant and lactating mice, and expression in the skin of nonpregnant mice has been induced by topical administration of estrogen and progesterone (Craig and Denhardt, 1991) . Consistent with those observations, we found markedly stronger immunostaining for osteopontin in lactating human breast as compared with nonlactating breast. Also consistent with hormonal induction, hypersecretory endometrial glands associated with pregnancy stained with particular intensity and more strongly than the secretory endometrium in the absence of pregnancy. In this study, we did not examine the effect of pregnancy on osteopontin expression in the skin; however, we did determine with immunostaining that osteopontin is predominantly, and perhaps exclusively, restricted in skin to the sweat glands and the luminal surface of sweat ducts. To our knowledge, the cellular location of osteopontin in rodent skin has not been determined.
Although our study of human tissues revealed that osteopontin is widely expressed by epithelium, we also ) C detected osteopontin and its transcript in ganglion cells residing between muscle layers of the intestinal tract. Osteopontin expression by rodent auditory ganglia and nerves of the embryonic ear has been demonstrated previously (Mark et al., 1988; Swanson et al., 1989) ; hence, osteopontin expression may be associated with ganglion cells in a variety of tissues. In contrast to ganglia, we found that the smooth muscle cells and other interstitial cells of large and small bowel wall were negative for both osteopontin and its transcript. Giachelli et al. (1991) recently reported that rat aortic smooth muscle cells in culture express high levels of osteopontin mRNA; in contrast, we found no evidence of osteopontin or osteopontin transcript in association with smooth muscle of the various organs we examined, but we did not investigate aorta.
The finding of a GRGDS cell-binding domain in osteopontin provided the first indication that this protein might play a role in cell adhesion (Oldberg et al., 1986) ; in particular, it appears likely that osteopontin promotes the anchorage of osteoclasts to bone matrix. Cells attach to and spread on immobilized bone osteopontin (Somerman et al., 1989) , and intense osteopontin staining has been found by immunohistochemistry on bone surfaces at sites of osteoclast anchorage (Reinholt et al., 1990) . Moreover, soluble osteopontin and an osteopontin peptide, including the RGD domain, inhibited osteoclast binding to bone particles and also inhibited bone resorption in vitro (Miyauchi et al., 1991) . Thus, osteopontin associated with bone matrix may promote osteoclast adhesion and resorption of matrix. The role of osteopontin in epithelium is unknown; moreover, there may be structurally different forms of osteopontin with different functions. Multiple forms of osteopontin have been described, including differentially glycosylated species (Singh et al., 1990a) , forms with and without phosphorylation (Nemir et al., 1989; Chang and Prince, 1991) , with and without sulphation (Kubota et al., 1989; Nagata et al., 1989) , as well as naturally occurring proteolytic fragments (Senger et al., 1988; Senger et al., 1989a; Zhang et al., 1990; Ullrich et al., 1991) , and, as shown here, polymeric forms. There is also evidence supporting differential splicing of osteopontin transcripts, although there is no evidence, so far, for variability in expression of these spliced transcripts among tissues (Young et al., 1990) . In short, the extent to which different forms of osteopontin have different functional activities or restricted tissue distributions remains to be determined. However, it is clear that osteopontin derived from both epithelium and bone has a functional RGD cell-binding domain. As reported here, osteopontin expressed by breast epithelium and purified from human milk promoted attachment and spreading of a variety of cell types, including epithelial cells, and soluble GRGDS peptide blocked this process. Thus, osteopontin isolated from either bone (Somerman et al., 1989) or from breast milk behaved in similar fashion as adhesive proteins. Although there are alternative possibilities, a likely hypothesis is that osteopontin binds luminal epithelial cell surface integnns via its RGD domain.
The finding that osteopontin is widely distributed on surfaces of specific populations of epithelial cells in the gastrointestinal tract, bile ducts, pancreatic ducts, urinary and reproductive tracts, breast, salivary glands and ducts, sweat glands and ducts, and bronchi suggests that this protein may have a protective role in interactions between these epithelial surfaces and the external environment. if this were the case, the osteopontin present in breast milk might have a similar role in coating and thereby protecting the gastrointestinal epithelium of the nursing baby and the breast epithelium of the mother. Some bacterial strains have been reported to bind integrins on epithelial-like cells and thereby invade these cells in culture (Isberg and Leong, 1990; Falkow, 1991; Isberg, 1991) . Osteopontin might serve to prevent bacterial attachment through competition for these same receptors. Other observations also have suggested that osteopontin may play a role in host defense. For example, the mouse osteopontin gene has been localized to chromosome 5, in the region of Ric, a gene that confers Rickettsia resistance (Fet et al., 1989) , and the possibility remains that Ric is an allele of the osteopontin gene. Moreover, elevated concentrations of osteopontin have been observed in the blood of patients with gram-negative bacterial sepsis (Senger et al., 1988) , and interleukin-1 has been reported to increase osteopontin expression in vitro ain et al., 1990 ). Although we did not examine inflammatory conditions in this study, others have reported that activation of both Tlymphocytes and macrophage-like cells leads to marked increases in osteopontin mRNA levels (Patarca et al., 1989; Miyazaki et al., 1990) , and intradermal administration of osteopontin is reported to elicit a cellular infiltrate consisting primarily of macrophages (Singh et al., 1990b) .
In summary, this report provides the first compre- 
